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of Cell Migration
Yarrow et al. have identified a small molecule inhibitor
of cell migration, 3-(4-pyridyl)indole (“Rockout”), that
targets Rho-kinase via a novel screening method
using a scratch wound healing assay adapted to a
high-throughput format and automated microscopy.
Small molecule inhibitors are extremely useful for dis-
secting complex cellular events that require the coordi-
nation and regulation of many proteins. By inhibiting a
specific component of a biochemical network, one can
deduce its function in the process. A popular approach
has been to use pure proteins and screen for inhibitors
in activity assays. However, this limits the target to
known elements with known activities. A more difficult
and potentially fruitful approach is to design a “pheno-
typic screen” that assays the entire cellular process. In
this issue of Chemistry & Biology, Yarrow and col-
leagues have designed an innovative, imaging-based
screen for inhibitors of cell migration and have discov-ered the compound “Rockout,” which targets the cy-
toskeletal regulator Rho-kinase [1].
Cell migration is attractive as a target for phenotypic
small molecule screens because it relies on the integ-
ration of several processes and because it is essential
in many cell types. Wound healing, tissue formation,
immune responses, angiogenesis, and tumor cell me-
tastasis all depend on cell motility [2]. The process gen-
erally begins with an extracellular stimulus that triggers
a signal transduction cascade leading to polarized mi-
gration of the cell, which requires the reorganization of
actin filaments and microtubules, polarization of the se-
cretory apparatus, membrane protrusion, and dynamic
adhesion to the substrate [2, 3]. Although a variety of
stimuli can trigger migration, many aspects of the intra-
cellular pathways that contribute to cell polarization
and motility are conserved in multiple cell types and
species [3–5]. For example, Rho family GTPases—
namely Rho, Rac, and Cdc42—have conserved func-
tions in linking extracellular signals to rearrangements
of both actin microfilaments and microtubules [3, 4]. By
activating downstream effectors, these GTPases regu-
late processes that range from microtubule/actin in-
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264teractions at the leading edge of a migrating fibroblast t
wto polarizing actin structures in budding yeast [4, 6]. A
major goal is to understand how these Rho GTPases t
Pfunction to regulate polarity in diverse cellular pro-
cesses. t
mSmall molecule inhibitors have been used to study
the migration of living cells, and the most readily avail- b
mable compounds directly disrupt actin microfilaments
or microtubules [7, 8]. Treating migrating cells with such p
ecompounds can address the requirements of microtu-
bules or microfilaments in motile processes; however, a
athese experiments exclude information about upstream
regulation. Consequently, efforts have been made to l
cidentify small molecule inhibitors that target regulatory
proteins using phenotype-based assays [9–12]. These d
Capproaches have yielded inhibitors of factors such as
N-WASP, which activates the Arp2/3 complex and pro- m
pmotes actin polymerization [11]; Rho-kinase, which is
activated by the Rho GTPase and whose targets in-
tclude cytoskeletal components [10]; and myosin light
chain kinase, which regulates myosin activity [9]. Be- a
wcause cell migration is so complex, a comprehensive
understanding would be greatly facilitated by the dis- m
gcovery of additional, cell-permeable compounds that
target other regulators, such as the Rho GTPases b
sthemselves, additional downstream actin and microtu-
bule effectors, and factors that mediate interactions d
dbetween these two cytoskeletal elements [4].
In an unbiased approach to identify novel cell migra- s
rtion inhibitors, Yarrow and colleagues performed a vi-
sual screen based on classical wound healing assays
Rperformed in high-throughput format [12, 13] and iden-
tified a new Rho-kinase inhibitor, Rockout [1, 14]. In the s
tscreen, BS-C-1 cell monolayers were grown in 384-well ent and specific inhibitors of Rho-kinase. Rho-kinase
Figure 1. High-Throughput Screening Using a Scratch Wound Healing Assay
(A) Screening protocol in 384-well plate format.
(B) Schematic of wound healing at a scratch boundary, where bordering cells initiate lamellar protrusion and migration toward the center of
the wound.
(C) Schematic of 16 wells before and after treatment with compounds during wound healing. Three wells, outlined in red, show defects in
wound closure indicating the presence of inhibitory compounds.issue culture plates. The monolayers in each well were
ounded with a pin transfer device normally used for
ransferring small volumes of liquid to 96-well plates.
ins were placed in the wells and then moved laterally
o introduce a wound of uniform size and shape to each
onolayer before the addition of small molecules. A li-
rary of 16,000 small molecules was screened. Cell
onolayers were allowed a 7-hr recovery period before
rocessing for microscopy (Figure 1) [14]. An image of
ach well was captured using automated microscopy
nd compounds affecting wound healing were grouped
ccording to phenotype. Compounds that were se-
ected for further analysis decreased cell migration,
aused aberrant morphology, increased the mitotic in-
ex, or caused a combination of these phenotypes.
ompounds that caused gross disruptions of the cell
onolayer were interpreted to be toxic and were not
ursued.
A set of seven secondary assays was then performed
o test the selected compounds for their effects on the
ctin cytoskeleton as well as other processes. Rockout
as identified as a nontoxic molecule that changed the
orphology and dynamics of cells at the wound mar-
in. In secondary assays, Rockout inhibited cell bleb-
ing and the formation of stress fibers and focal adhe-
ions. Importantly, Rockout did not disrupt actin filaments
irectly. Together these results suggest that Rockout
isrupts the Rho pathway. Additional experiments
howed that Rockout does not act on Rho itself, but
ather inhibits the activity of Rho-kinase.
Although Rockout is less potent than the pre-existing
ho-kinase inhibitor Y-27632 [10], it provides a new
caffold that could be optimized to develop more po-
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265is of interest as a small molecule target because it is
activated by Rho and because it phosphorylates cy-
toskeletal proteins, including myosin light chain, which
contributes directly to stress fiber formation [15]. Other
substrates of Rho-kinase include factors that function
in cytokinesis and membrane ruffling [16].
Like a similar screen performed previously [12], the
strategy used in this study has several advantages. For
one, the readout is the direct visualization of a complex
phenomenon (wound healing) whose proper comple-
tion relies on several fundamental mechanisms (signal
transduction, cytoskeletal reorganization, etc). This makes
possible the identification of compounds that affect
regulators of multiple pathways that contribute to cell
migration. In addition, the screen automatically selects
for small molecules that are cell-permeable. Although
the current study focused on finding compounds that
target actin-associated proteins, one can imagine using
the same screening method to find compounds that
target other processes that are important for cell migra-
tion. For example, in standard wound healing assays,
the Golgi apparatus orients toward the site of polarized
growth in response to the introduction of a scratch
wound, and this orientation can be quantified [17]. One
might discover interesting inhibitors in a screen for
small molecules that disrupt Golgi orientation in this
assay.
The authors of this study were able to identify a
target of Rockout using a combination of careful exper-
imentation and inference. However, target identification
is an inherent challenge in phenotypic small molecule
screens and it is often necessary to use other methods
to identify the target or targets of a compound. For ex-
ample, affinity chromatography methods can be used
for target identification by coupling the compound of
interest to a matrix to retrieve target proteins from cel-
lular extracts [18]. Another approach, known as the
small molecule yeast-three-hybrid system, detects
compound-protein interactions in living yeast cells [19].
Here, the interaction between the compound and its
target protein activates the expression of a reporter
gene. Although such approaches have been used suc-
cessfully, a major challenge remains to develop im-
proved methods for identifying targets in phenotypic
screens.
In summary, the study by Yarrow and colleagues de-
monstrates the use of a high-throughput screening ap-
proach that is based on a wound healing assay. This
work has set the stage for the identification of novelinhibitors as well as potentially novel targets. Depend-
ing on how the microscopy assay is applied, it could
be used to screen for compounds that affect diverse
migration-related pathways associated with wound
healing. We are eagerly waiting to see what crawls out
next.
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